✦ LIBER ✦

P.3.d.063 Lurasidone for maintenance of efficacy in patients with schizophrenia: a double-blind, placebo-controlled, randomised withdrawal study

✍ Scribed by Tandon, R.; Loebel, A.; Phillips, D.; Pikalov, A.; Hernandez, D.; Mao, Y.; Cucchiaro, J.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

EPA-1722 – A double-blind, placebo-contr

✍ Tandon, R.; Loebel, A.; Phillips, D.; Pikalov, A.; Hernandez, D.; Mao, Y.; Cucch 📂 Article 📅 2014 🏛 Elsevier Science 🌐 French ⚖ 72 KB

Poster #T233 A DOUBLE-BLIND, PLACEBO-CON

✍ Tandon, Rajiv; Loebel, Antony; Phillips, Debra; Pikalov, Andrei; Hernandez, Davi 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 95 KB

P.3.d.044 A randomised, double-blind, pl

✍ Kocyigit, Y.; Ayhan, Y.; Yoca, G.; Karahan, S.; Yazici, M.K. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 59 KB

A randomised, double-blind, placebo-cont

✍ Gual, Antoni; He, Yuan; Torup, Lars; van den Brink, Wim; Mann, Karl 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 872 KB

Efficacy and tolerability of once-daily

✍ R. Kahn; C. Schulz; V. Palazov; E. Reyes; D. Meulien; M. Brecher; O. Svensson; H 📂 Article 📅 2007 🏛 Elsevier Science 🌐 French ⚖ 47 KB

P.3.d.033 Cariprazine in acute exacerbat

✍ Lieberman, J.A.; Cutler, A.J.; Wan, S.; Migliore, R.; Ruth, A.; Laszlovszky, I.; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 73 KB